Your browser doesn't support javascript.
loading
Systemically Administered RNAi Molecule Sensitizes Malignant Pleural Mesotheliomal Cells to Pemetrexed Therapy.
Abu Lila, Amr S; Fukushima, Masakazu; Huang, Cheng-Long; Wada, Hiromi; Ishida, Tatsuhiro.
  • Abu Lila AS; Department of Pharmacokinetics and Biopharmaceutics, Institute of Biomedical Sciences, Tokushima University , Tokushima, Japan.
  • Fukushima M; Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Zagazig University , Zagazig 44519, Egypt.
  • Huang CL; Department of Pharmaceutics, Faculty of Pharmacy, Hail University , Hail 2440, Saudi Arabia.
  • Wada H; Department of Cancer Metabolism and Therapy, Institute of Biomedical Sciences, Tokushima University , Tokushima 770-8505, Japan.
  • Ishida T; Department of Thoracic Surgery, Faculty of Medicine, Kyoto University , Kyoto 606-8501, Japan.
Mol Pharm ; 13(11): 3955-3963, 2016 11 07.
Article en En | MEDLINE | ID: mdl-27740765
Search on Google
Banco de datos: MEDLINE Asunto principal: ARN Interferente Pequeño / Pemetrexed / Neoplasias Pulmonares / Mesotelioma Límite: Animals / Humans / Male Idioma: En Año: 2016 Tipo del documento: Article
Search on Google
Banco de datos: MEDLINE Asunto principal: ARN Interferente Pequeño / Pemetrexed / Neoplasias Pulmonares / Mesotelioma Límite: Animals / Humans / Male Idioma: En Año: 2016 Tipo del documento: Article